A Prospective, Multi-Center, Randomized, Controlled Clinical Trial Designed to Evaluate the Safety and Preliminary Efficacy of V404 PDS in Chronic Noninfectious Uveitis
Latest Information Update: 14 Jan 2020
Price :
$35 *
At a glance
- Drugs V 404 (Primary)
- Indications Uveitis
- Focus Adverse reactions
- Sponsors ForSight VISION4
- 04 Mar 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 09 May 2014 New trial record